AJP - Lung Cellular and Molecular Physiology, Vol 271, Issue 3 419-L424, Copyright © 1996 by American Physiological Society

ARTICLES

Altered vasoreactivity in lungs isolated from rats exposed to nitric oxide gas

M. Oka, M. Ohnishi, H. Takahashi, S. Soma, K. Hasunuma, K. Sato and S. Kira
Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan.

A rebound phenomenon (severe arterial desaturation and pulmonary vasoconstriction) has been observed in some patients with pulmonary hypertension after sudden discontinuation of nitric oxide (NO) inhalation therapy. The mechanism responsible for this phenomenon is unknown. It has recently been reported that NO synthase (NOS) can be inhibited by NO as a negative feedback mechanism. We therefore hypothesized that this rebound phenomenon might be attributable to reduced endogenous NO production due to inhibition of pulmonary endothelial NOS (eNOS) activity by inhaled NO. To test this hypothesis, vasoreactivities were compared in isolated perfused lungs from rats exposed to 40 ppm NO gas and room air for 2 days. The pressor responses to angiotensin II and hypoxia of lungs from rats exposed to NO were markedly potentiated and their depressor response to bradykinin was considerably impaired, whereas that to sodium nitroprusside was preserved, compared with the responses of those exposed to room air. This altered pulmonary vasoreactivity was also induced by lower concentrations of inhaled NO (as low as 1 ppm) and was completely reversed by discontinuation of NO inhalation for several (< 8) hours. The expression of eNOS mRNA by lungs isolated from rats exposed to 40 ppm NO and room air for 2 days did not differ. These results suggest that pulmonary endogenous NO production is reversibly reduced after relatively short-term NO inhalation, which probably inhibits eNOS activity directly. We speculate that reduced production of pulmonary endogenous NO by exogenous (inhaled) NO could be the mechanism responsible for this rebound phenomenon.

This article has been cited by other articles:

				Y. Gao, S. Dhanakoti, E. M. Trevino, X. Wang, F. C. Sander, A. D. Portugal, and J. U. Raj Role of cGMP-dependent protein kinase in development of tolerance to nitric oxide in pulmonary veins of newborn lambs Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L786 - L792. [Abstract] [Full Text] [PDF]

				V.I. Peinado, S. Santos, J. Ramirez, J. Roca, R. Rodriguez-Roisin, and J.A. Barbera Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study Eur. Respir. J., August 1, 2002; 20(2): 332 - 338. [Abstract] [Full Text] [PDF]

				D. N. Cornfield, R. C. Maynard, R.-A. O. deRegnier, S. F. Guiang III, J. E. Barbato, and C. E. Milla Randomized, Controlled Trial of Low-dose Inhaled Nitric Oxide in the Treatment of Term and Near-term Infants With Respiratory Failure and Pulmonary Hypertension Pediatrics, November 1, 1999; 104(5): 1089 - 1094. [Abstract] [Full Text]

				J. Zhang, L. W. Velsor, J. M. Patel, E. M. Postlethwait, and E. R. Block Nitric oxide-induced reduction of lung cell and whole lung thioredoxin expression is regulated by NF-kappa B Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L787 - L793. [Abstract] [Full Text] [PDF]

				D. U. Frank, D. J. Horstman, G. N. Morris, R. A. Johns, and G. F. Rich Regulation of the endogenous NO pathway by prolonged inhaled NO in rats J Appl Physiol, September 1, 1998; 85(3): 1070 - 1078. [Abstract] [Full Text] [PDF]

				J. Zhang, Y. D. Li, J. M. Patel, and E. R. Block Thioredoxin overexpression prevents NO-induced reduction of NO synthase activity in lung endothelial cells Am J Physiol Lung Cell Mol Physiol, August 1, 1998; 275(2): L288 - L293. [Abstract] [Full Text] [PDF]

				D. D. Ivy, J. P. Kinsella, J. W. Ziegler, and S. H. Abman Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease J. Thorac. Cardiovasc. Surg., April 1, 1998; 115(4): 875 - 882. [Abstract] [Full Text] [PDF]